AKT1 and Alzheimer disease: Increasing the lncRNA MEG3 reduces neuronal damage and cognitive impairment. Also, upregulation of the lncRNA MEG3 inhibits the activation of astrocytes in hippocampal tissues in AD by inhibiting the PI3K/Akt signaling pathway.